BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23645882)

  • 1. Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2.
    Qian X; Gu L; Ning H; Zhang Y; Hsueh EC; Fu M; Hu X; Wei L; Hoft DF; Liu J
    J Immunol; 2013 Jun; 190(11):5894-902. PubMed ID: 23645882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell-intrinsic prostaglandin E
    Lee J; Aoki T; Thumkeo D; Siriwach R; Yao C; Narumiya S
    J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling.
    Boniface K; Bak-Jensen KS; Li Y; Blumenschein WM; McGeachy MJ; McClanahan TK; McKenzie BS; Kastelein RA; Cua DJ; de Waal Malefyt R
    J Exp Med; 2009 Mar; 206(3):535-48. PubMed ID: 19273625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1.
    Chang HH; Young SH; Sinnett-Smith J; Chou CE; Moro A; Hertzer KM; Hines OJ; Rozengurt E; Eibl G
    Am J Physiol Cell Physiol; 2015 Nov; 309(10):C639-49. PubMed ID: 26310818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway.
    Qian X; Zhang J; Liu J
    J Biol Chem; 2011 Jan; 286(3):2111-20. PubMed ID: 21097507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2-induced IL-23p19 subunit is regulated by cAMP-responsive element-binding protein and C/AATT enhancer-binding protein β in bone marrow-derived dendritic cells.
    Kocieda VP; Adhikary S; Emig F; Yen JH; Toscano MG; Ganea D
    J Biol Chem; 2012 Oct; 287(44):36922-35. PubMed ID: 22977257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431.
    Kanda N; Watanabe S
    J Invest Dermatol; 2002 Nov; 119(5):1080-9. PubMed ID: 12445196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous prostaglandin E
    Samuchiwal SK; Balestrieri B; Raff H; Boyce JA
    J Biol Chem; 2017 May; 292(20):8195-8206. PubMed ID: 28341741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGE2 potentiates tonicity-induced COX-2 expression in renal medullary cells in a positive feedback loop involving EP2-cAMP-PKA signaling.
    Steinert D; Küper C; Bartels H; Beck FX; Neuhofer W
    Am J Physiol Cell Physiol; 2009 Jan; 296(1):C75-87. PubMed ID: 19005164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites.
    Bradbury D; Clarke D; Seedhouse C; Corbett L; Stocks J; Knox A
    J Biol Chem; 2005 Aug; 280(34):29993-30000. PubMed ID: 15970595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.
    Sokolowska M; Chen LY; Liu Y; Martinez-Anton A; Qi HY; Logun C; Alsaaty S; Park YH; Kastner DL; Chae JJ; Shelhamer JH
    J Immunol; 2015 Jun; 194(11):5472-5487. PubMed ID: 25917098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.
    Holt DM; Ma X; Kundu N; Collin PD; Fulton AM
    J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mechanical strain on the function of Gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor.
    Cherian PP; Cheng B; Gu S; Sprague E; Bonewald LF; Jiang JX
    J Biol Chem; 2003 Oct; 278(44):43146-56. PubMed ID: 12939279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
    Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E
    Wan M; Tang X; Rekha RS; Muvva SSVJR; Brighenti S; Agerberth B; Haeggström JZ
    FASEB J; 2018 May; 32(5):2827-2840. PubMed ID: 29401596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IL17A and IL17F loci have divergent histone modifications and are differentially regulated by prostaglandin E2 in Th17 cells.
    Adamik J; Henkel M; Ray A; Auron PE; Duerr R; Barrie A
    Cytokine; 2013 Oct; 64(1):404-12. PubMed ID: 23800789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 modulates IL-8 expression through formation of a multiprotein enhanceosome in human colonic epithelial cells.
    Srivastava V; Dey I; Leung P; Chadee K
    Eur J Immunol; 2012 Apr; 42(4):912-23. PubMed ID: 22531917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E
    Mangelsen E; Rothe M; Schulz A; Kourpa A; Panáková D; Kreutz R; Bolbrinker J
    Cells; 2020 May; 9(5):. PubMed ID: 32438662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
    Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E
    Li H; Chen HY; Liu WX; Jia XX; Zhang JG; Ma CL; Zhang XJ; Yu F; Cong B
    Immunol Lett; 2017 Nov; 191():63-72. PubMed ID: 28963072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.